One mn doses for Nepal: Kathmandu urges India for continued vaccines supply

One million doses of Oxford/Astrazenca vaccine 'Covishield' produced by the Serum Institute of India (SII) landed in Nepali capital Kathmandu on Thursday

Topics
Coronavirus Vaccine | India Nepal ties | KP Oli

ANI  |  Asia 

Coronavirus vaccine, Covishield
The vaccine that arrived in Nepal as grant assistance would be first administered to frontline workers.

As Nepal has received a million doses of the COVID-19 vaccine from India, the Himalayan nation is set to start inoculation drive against the infection from next week.

Nepal's Minister of Health and Population, Hridayesh Tripathi, on Thursday, announced the commencement of the vaccination drive from next week and requested India for continued support to deliver the adequate number of vaccines to inoculate 72 percent of the nearly 30 million population of Nepal.

"We will start utilising vaccines within a week or ten days and we already have fixed the priority groups for inoculation," Tripathi said while addressing the ceremony of receiving the vaccines from India that landed in Kathmandu on Thursday.

One million doses of Oxford/Astrazenca vaccine 'Covishield' produced by the Serum Institute of India (SII) landed in Nepali capital Kathmandu on Thursday afternoon. The vaccine that arrived in Nepal as grant assistance would be first administered to frontline workers.

"We have estimated that we would be requiring at least four million additional vaccines. After the beginning of the inoculation drive, we will face a situation that demands delivery of vaccines before the vaccination campaign ends," Tripathi said.

"This for now is a gift from India. Later on the basis of our needs and demands, we will advance forward with the purchase of vaccines. The vaccine procurement would be transparent for which we will require the continued support of Government of India and Indian Ambassador," he added.

Prime Minister Narendra Modi on Thursday evening promised to continue to support Nepal in the fight against the COVID-19 pandemic.

"Thank You PM @kpsharmaoli. India remains committed to assisting the people of Nepal in fighting the COVID-19 pandemic. The vaccines being made in India will also contribute to the global efforts to contain the pandemic," PM Modi replied to the tweet by Nepali caretaker Prime Minister KP Sharma Oli who thanked India for the generous grant of one million doses of COVID vaccine.

Indian Ambassador to Nepal, Vinay Mohan Kwatra, in his speech, also assured that India would continue to work for the spirit of people first and Neighborhood first Policy.

"One million doses of Indian Vaccine is also a testimony to what the Indian Prime Minister has repeatedly said that Indian capacity- capability in all areas of economic endeavour would always have in their mind, 'People first and Neighborhood First'. The One million doses of Indian manufactured COVID vaccine is a gift from people and Government of India to people and Government of Nepal," Ambassador Kwatra said.

India, the world's largest vaccine producer as well as pharmacy of the world, has already started shipping out to its neighbours within a week of its national rollout.

On Wednesday, India sent 150,000 doses of vaccines to Bhutan and 100,000 doses to the Maldives.

"We prefer the Indian vaccine because it has been already rolled out in other neighbouring countries. Also, we have a proper system to store these vaccines," Director General of Department of Health Services, Nepal- Dipendra Raman Singh told ANI.

Nepal earlier last week approved the emergency use of the SII produced Covishield marking it as the first vaccine to get approval in the Himalayan nation.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Fri, January 22 2021. 06:48 IST
RECOMMENDED FOR YOU